. (2010). The novel pyrrolidine nor-lobelane analog UKCP-110 cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal Of Pharmacology And Experimental Therapeutics, 335(3), 841-51. https://doi.org/10.1124/jpet.110.172742
